Ishiguro, H., Saji, S., Nomura, S., Tanaka, S., Ueno, T., Onoue, M., . . . Toi, M. (2017). A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S−1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG‐M01 study). Cancer Med.
استشهاد بنمط شيكاغوIshiguro, Hiroshi, et al. "A Phase I/II Pharmacokinetics/pharmacodynamics Study of Irinotecan Combined With S−1 for Recurrent/metastatic Breast Cancer in Patients With Selected UGT1A1 Genotypes (the JBCRG‐M01 Study)." Cancer Med 2017.
MLA استشهادIshiguro, Hiroshi, et al. "A Phase I/II Pharmacokinetics/pharmacodynamics Study of Irinotecan Combined With S−1 for Recurrent/metastatic Breast Cancer in Patients With Selected UGT1A1 Genotypes (the JBCRG‐M01 Study)." Cancer Med 2017.